Sanofi Ventures is the corporate venture capital arm of Sanofi. We have the ability to seed and to lead financings in early-stage companies with innovative ideas and transformative new products and technologies that are of strategic interest to Sanofi. Among these areas are rare diseases, oncology, immunology and inflammation, vaccines, potential cures in other core areas of Sanofis business footprint, and digital health solutions. At Sanofi Ventures, we are different from traditional venture capital firms. In addition to financing, we offer our portfolio companies access to Sanofis established expertise and capabilities in science, preclinical and clinical development, regulatory, manufacturing, market access, commercialization, and more. We invest in early-stage companies developing transformative technologies and products that are considered too early for business development. Sanofi Ventures has an expedited decision making process consisting of a small investment committee of senior Sanofi executives. Our success is not driven by financial return, but defined by our ability to build strong relationships with innovators and entrepreneurs which can lead to future strategic collaborations and leading-edge product opportunities. We are fully engaged with the companys management through board positions or advisory committee membership.